Company Story & Identity

Who they are
Hims & Hers Health, Inc., founded in 2017 in San Francisco, brings a direct-to-consumer telehealth approach to personal wellness—starting with hair loss and men’s health, expanding into women’s products, mental health, and now GLP‑1 weight‑loss treatments hims+15Wikipedia+15hims+15.

Founding & Growth
Founded by Jack Abraham, Andrew Dudum, and Hilary Coles (with Dudum officially CEO since 2016), the company grew quickly through venture funding—reaching unicorn status in early 2019—and went public via SPAC in early 2021 at a valuation of around $1.6 billion Hims+3Wikipedia+3Tracxn+3. By 2023, revenue had reached about $872 million Wikipedia.

Leadership
Andrew Dudum (CEO) co‑founded the company and has led the mission to destigmatize personal healthcare through easy, respectful access hims+6Hims+6Quartr+6. COO Melissa Baird brings DTC operations experience; Soleil Teubner Boughton leads legal and compliance efforts Hims+2Yahoo Finance+2.

Mission & Vision

Hims designed its model so that people can connect via telehealth with licensed providers in their state, receive personalized treatment plans, and maintain a direct line to care through the Hims app—always framed around clarity, care, and feeling supported Investors.com+12hims+12hims+12. Their vision grew from accessible solutions for sensitive issues to a broader mission of making wellness approachable for everyone Quartr+1.

GLP-1 Program Overview

Medications offered
Hims makes a wide spectrum of GLP‑1 options available:

• Compounded semaglutide (same active ingredient as Ozempic/Wegovy, custom‑prepared—FDA‑unreviewed)

• Brand-name Wegovy® (semaglutide, higher dose, FDA-approved for weight loss)

• Ozempic® (semaglutide, approved for diabetes but prescribed off-label for weight loss)

• Mounjaro® (tirzepatide, FDA-approved for diabetes)

• Zepbound® (tirzepatide, FDA-approved for weight loss)

• Generic liraglutide (similar to Saxenda®), plus personalized oral medication kits combining bupropion, metformin, topiramate, vitamin B12, and naltrexone Business Insider+15hims+15hims+15.

Dosages & options
Dosing and selection depend on your profile and state, guided by your provider. The oral kits are once- or twice-daily and tailored to your needs. GLP‑1 injections range from daily (liraglutide) to weekly (semaglutide/tirzepatide options) hims+9hims+9hims+9.

Program benefits

• Personalized plans with regular follow-up available through the app

• Access to both compounded and brand‑name GLP‑1s depending on eligibility and location

• Ongoing support from providers for dosage adjustments and side effect management himshims+1.

Pricing & Payment Flexibility

GLP-1 injectable plans start as low as $199/month with a 12-month upfront plan; oral kits from $69/month with 10-month upfront plans hims+1. Hims also offers 1‑, 4‑, or 6‑month plans in some cases Barron's+15hims+15Financial Times+15.

Insurance isn't required, and treatments are eligible for FSA/HSA reimbursement hims+1.

How It Works

• Begin with an online consultation—sometimes without video, depending on state

• A licensed provider reviews your health and personal goals

• If approved, you receive a customized treatment plan

• Communication and follow-ups happen through the Hims app—for questions, adjustments, and encouragement himshims+3hims+3hims+3hims+1.

Customer Experience & Tools

The Hims website and app are user‑friendly and welcoming, with easily navigated eligibility checkers and clear treatment paths hims+1. The app offers messaging, curated wellness content, meal suggestions, and stronger habits to support your journey hims.

Reported outcomes (as of October 2024):

• Oral kits users: ~7.5 lb lost by Day 28; ~9 lb by Day 56

• GLP‑1 users: ~9.3 lb by Day 28; ~12.5 lb by Day 56
  Over 90% felt healthier, more confident, and had mood improvements hims+12hers+12hims+12.

Medical Support & Safety

Care is overseen by licensed medical professionals. Providers guide dosing and manage side effects like GI discomfort with care. Screening helps avoid contraindications. The platform stresses doctor-involved care and ongoing support hims+2hims+2.

Recent news underlines the importance of choosing platforms that partner with FDA-registered pharmacies and licensed professionals—Hims is noted in such trusted contexts hims+11Vogue+11hims+11.

Shipping & Delivery

Hims partners with reputable pharmacies (including FDA-registered compounded pharmacies) to deliver medication. Delivery times and packaging quality are generally reliable, with follow-up support via messaging. (Specific shipping timelines weren’t detailed in sources.)

Credibility & Compliance

Hims is a licensed telehealth provider operating nationally (subject to state-by-state availability). Brand-name medications are FDA-approved; compounded options come from FDA-registered pharmacies but aren’t individually reviewed—Hims is transparent about these distinctions hims.

News & Recent Updates

• Hims' revenue surged in early 2025, driven by GLP‑1 demand; they responded to regulatory shifts ending compounded semaglutide production Business Insider+1.

• Partnerships with brand-name providers (e.g., Wegovy via Novo) emerged as the company adapts Financial Times.

In Summary

Hims offers a thoughtful, supportive path to weight loss medication—with real personalization, clinician involvement, clear pricing, and ease-of-access through its app. Many users see meaningful results, feel empowered on their journey, and appreciate the blend of medical trust and approachable care.

Getting started feels like talking to a trusted guide who’s there for you—steady, responsive, and invested in your wellbeing.